EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inherent PD ‐ L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis

Yoon Jin Cha iD, Hye Min Kim, Ja Seung Koo iD

Thoracic Cancer · 2025

DOI: 10.1111/1759-7714.70004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Yoon Jin Cha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: B7-H1 Antigen, Lung Neoplasms, Breast Neoplasms, Macrophages, Alveolar. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to determine the impact of inherent programmed death‐ligand 1 (PD‐L1)‐expressing alveolar macrophages (AMs) on the combined positive score (CPS) of PD‐L1 (22C3) in metastatic breast cancer in the lungs.

Methods

A total of 87 patients with pulmonary metastases of breast cancer were included in this study. Immunohistochemical staining of various PD‐L1 antibodies was performed. The CPSs and CPSs excluding the number of PD‐L1 positive AMs [CPS(NAM)s] with PD‐L1 (22C3) were determined and compared.

Results

Among 87 enrolled patients, 22 had luminal A breast cancer, 24 had luminal B breast cancer, 13 had HER‐2‐positive breast cancer, and 28 had triple‐negative breast cancer (TNBC). CPSs ≥ 10 was observed only in luminal B (12.5%) and TNBC (35.7%) subtypes ( p < 0.001), whereas CPS(NAM)s ≥ 10 was observed only in TNBC (14.3%) ( p = 0.011). Changes from the CPS‐positive to the CPS(NAM)‐negative status occurred in nine cases (10.3%), with significantly higher proportions being observed in the luminal B (12.5%) and TNBC (21.4%) subtypes ( p = 0.007). Tumors showing changes from the CPS‐positive to the CPS(NAM)‐negative status were larger ( p < 0.001); similar findings were observed in the TNBC subgroup ( p = 0.001).

Conclusion

The inclusion of PD‐L1 expressing AMs leads to differences in CPS positivity, especially in large TNBC subtype tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenLung NeoplasmsBreast NeoplasmsMacrophages, AlveolarBiomarkers, TumorHumansFemaleMiddle AgedAdultAgedPrognosis

Stichwörter der Autor:innen

PD‐L1alveolar macrophagesbreast cancerlung metastasis

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.

ORCID-Profile: Yoon Jin Cha, Ja Seung Koo

Zitieren

APA

Cha, Y. J., Kim, H. M., & Koo, J. S. (2025). Inherent PD ‐ L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70004

Vancouver

Cha YJ, Kim HM, Koo JS. Inherent PD ‐ L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70004

BibTeX
@article{Cha2025,
  author = {Cha, Yoon Jin and Kim, Hye Min and Koo, Ja Seung},
  title = {Inherent PD ‐ L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis},
  journal = {Thoracic Cancer},
  year = {2025},
  doi = {10.1111/1759-7714.70004}
}
Kostenlos starten →